Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban - guidance (TA697)

Andexanet alfa is recommended as an option for reversing anticoagulation from apixaban or rivaroxaban in adults with life-threatening or uncontrolled bleeding, only if requirements are met as outlined in guidance.

National Institute for Health and Care Excellence